5th Circ. Deals Biden A Loss in Medicare Drug Pricing Row
A Fifth Circuit panel majority said that a healthcare trade association has standing to challenge the Biden administration's Medicare drug pricing program, allowing the group to sidestep agency administrative procedure and...To view the full article, register now.
Already a subscriber? Click here to view full article